American Bio Medica Corporation (NASDAQ:ABMC), a global provider of immunoassay diagnostic test kits, exercise volition give up Second Quarter 2008 results at complete of market steady Tuesday, August 12, 2008, and will clinch its conference call to discuss the Second Quarter results without interruption Wednesday, August 13, 2008, at 11 AM Eastern Time (10 AM Central Time).
This elect is being webcast by Thomson Financial and can be accessed at ABMC’s Web position at www.abmc.com/investor/. Investors and interested parties are invited to have a part in. The webcast wish be in listen-only degree. Listeners are requested to be online at least fifteen minutes early to register, as well as to download and install any complimentary audio software that might be required. To ask questions, you are invited to participate by phone. Within the United States, dial 1-800-820-0231 and internationally, sun-dial 416-640-5926.
The call will be available for replay on the company’session website at www.abmc.com/investor/ on account of 30 days.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson’s individual investor passage-way, powered by means of StreetEvents.Institutional investors be possible to access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.
About ABMC:
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world’s most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC’s Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R), RDS(R) InCup(R), Rapid TOX(R), and Rapid TOX Cup(R) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) and Rapid STAT(TM) tests for the presence or absence of drugs of abuse in oral fluids. ABMC’s Rapid Reader(R) is a compact, portable device that, when coupled to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.
Мой блог находят по следующим фразам
- York County proposed drug test policy
- vin murria
- "Jennifer Taule Anzalone"
- ydr county new hires
- belk for judge; charlotte
- italian parliament cocaine